LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
Year: 2019
Type: article
Abstract: Mutations in LRRK2 and GBA1 are common genetic risk factors for Parkinson's disease (PD) and major efforts are underway to develop new therapeutics that target LRRK2 or glucocerebrosidase (GCase). Here we describe a mechanistic and therapeutic convergence of LRRK2 and GCase in neurons derived from patients with PD. We find that GCase activity was reduced in dopaminergic (DA) neurons derived from PD patients with LRRK2 mutations. Inhibition of LRRK2 kinase activity results in increased GCase activity in DA neurons with either LRRK2 or GBA1 mutations. This increase is sufficient to partially rescue accumulation of oxidized dopamine and alpha-synuclein in PD patient neurons. We have identified the LRRK2 substrate Rab10 as a key mediator of LRRK2 regulation of GCase activity. Together, these results suggest an important role of mutant LRRK2 as a negative regulator of lysosomal GCase activity.
Source: Nature Communications
Institution: Northwestern University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,200
Funders: U.S. Department of Health and Human Services, Michael J. Fox Foundation for Parkinson's Research, Northwestern University, Deutsche Forschungsgemeinschaft, National Institutes of Health, National Institute on Aging, National Cancer Institute, National Institute of Neurological Disorders and Stroke
Awards: G1284175734, G2514411979, G3077598534, General Motor Control Mechanisms and Disease Training Program, The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein, G4646819402, G6544658276, The Role of Lysosomal Glucocerebrosidase in Synucleinopathies, G8056093040, G8445701587, Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease, Predoctoral and Postdoctoral Training Program in Aging and Dementia, The Robert H. Lurie Comprehensive Cancer Center
OpenAlex ID: W2994242284
